Publication:
Prevention of Neural Tube Defects in Europe: A Public Health Failure

dc.contributor.authorMorris, Joan K
dc.contributor.authorAddor, Marie-Claude
dc.contributor.authorBallardini, Elisa
dc.contributor.authorBarisic, Ingeborg
dc.contributor.authorBarrachina-Bonet, Laia
dc.contributor.authorBraz, Paula
dc.contributor.authorCavero-Carbonell, Clara
dc.contributor.authorDen Hond, Elly
dc.contributor.authorGarne, Ester
dc.contributor.authorGatt, Miriam
dc.contributor.authorHaeusler, Martin
dc.contributor.authorKhoshnood, Babak
dc.contributor.authorLelong, Nathalie
dc.contributor.authorKinsner-Ovaskainen, Agnieszka
dc.contributor.authorKiuru-Kuhlefelt, Sonja
dc.contributor.authorKlungsoyr, Kari
dc.contributor.authorLatos-Bielenska, Anna
dc.contributor.authorLimb, Elizabeth
dc.contributor.authorO'Mahony, Mary T
dc.contributor.authorPerthus, Isabelle
dc.contributor.authorPierini, Anna
dc.contributor.authorRankin, Judith
dc.contributor.authorRissmann, Anke
dc.contributor.authorRouget, Florence
dc.contributor.authorSayers, Gerardine
dc.contributor.authorSipek, Antonin
dc.contributor.authorStevens, Sarah
dc.contributor.authorTucker, David
dc.contributor.authorVerellen-Dumoulin, Christine
dc.contributor.authorde Walle, Hermien E K
dc.contributor.authorWellesley, Diana
dc.contributor.authorWertelecki, Wladimir
dc.contributor.authorBermejo-Sanchez, Eva
dc.date.accessioned2021-08-20T19:06:11Z
dc.date.available2021-08-20T19:06:11Z
dc.date.issued2021
dc.description.abstractObjective: Thirty years ago it was demonstrated that folic acid taken before pregnancy and in early pregnancy reduced the risk of a neural tube defect (NTD). Despite Public Health Initiatives across Europe recommending that women take 0.4 mg folic acid before becoming pregnant and during the first trimester, the prevalence of NTD pregnancies has not materially decreased in the EU since 1998, in contrast to the dramatic fall observed in the USA. This study aimed to estimate the number of NTD pregnancies that would have been prevented if flour had been fortified with folic acid in Europe from 1998 as it had been in the USA. Design and Setting: The number of NTD pregnancies from 1998 to 2017 that would have been prevented if folic acid fortification had been implemented in the 28 countries who were members of the European Union in 2019 was predicted was predicted using data on NTD prevalence from 35 EUROCAT congenital anomaly registries and literature searches for population serum folate levels and folic acid supplementation. Results: From 1998 to 2017 an estimated 95,213 NTD pregnancies occurred amongst 104 million births in the 28 countries in the EU, a prevalence of 0.92 per 1,000 births. The median serum folate level in Europe over this time period was estimated to be 14.1 μg/L. There is a lack of information about women taking folic acid supplements before becoming pregnant and during the first trimester of pregnancy, with one meta-analysis indicating that around 25% of women did so. An estimated 14,600 NTD pregnancies may have been prevented if the European countries had implemented fortification at the level adopted by the USA in 1998 and 25% of women took folic acid supplements. An estimated 19,500 NTD pregnancies would have been prevented if no women took folic acid supplements. Conclusions: This study suggests that failure to implement mandatory folic acid fortification in the 28 European countries has caused, and continues to cause, neural tube defects to occur in almost 1,000 pregnancies every year.es_ES
dc.description.peerreviewedes_ES
dc.format.page647038es_ES
dc.format.volume9es_ES
dc.identifier.citationFront Pediatr . 2021 Jun 24;9:647038.es_ES
dc.identifier.doi10.3389/fped.2021.647038es_ES
dc.identifier.issn2296-2360es_ES
dc.identifier.journalFrontiers in Pediatricses_ES
dc.identifier.pubmedID34249803es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/13301
dc.language.isoenges_ES
dc.publisherFrontiers Media
dc.relation.publisherversionhttps://doi.org/10.3389/fped.2021.647038es_ES
dc.repisalud.centroISCIII::Instituto de Investigación de Enfermedades Raras (IIER)es_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsopen accesses_ES
dc.rights.licenseAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectEuropees_ES
dc.subjectFolic acides_ES
dc.subjectFortificationes_ES
dc.subjectNeural tube defectses_ES
dc.subjectPreventiones_ES
dc.titlePrevention of Neural Tube Defects in Europe: A Public Health Failurees_ES
dc.typeresearch articlees_ES
dc.type.hasVersionVoRes_ES
dspace.entity.typePublication
relation.isAuthorOfPublication5764d316-caf4-47a6-b03f-4cfdc5b2e892
relation.isAuthorOfPublication.latestForDiscovery5764d316-caf4-47a6-b03f-4cfdc5b2e892
relation.isPublisherOfPublication9f9fa5ea-093b-43d8-bf2c-5bd65d08a802
relation.isPublisherOfPublication.latestForDiscovery9f9fa5ea-093b-43d8-bf2c-5bd65d08a802

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
PreventionOfNeuralTube_2021.pdf
Size:
214.49 KB
Format:
Adobe Portable Document Format
Description:
Artículo principal
Loading...
Thumbnail Image
Name:
PreventionOfNeuralTubeSupplementaryMaterial_2021.pdf
Size:
120.37 KB
Format:
Adobe Portable Document Format
Description:
Material Suplementario